| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
5,121 |
4,353 |
$772K |
| D0999 |
Unspecified diagnostic procedure, by report |
1,749 |
1,317 |
$613K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
800 |
691 |
$152K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
480 |
411 |
$80K |
| G0467 |
Federally qualified health center (fqhc) visit, established patient; a medically-necessary, face-to-face encounter (one-on-one) between an established patient and a fqhc practitioner during which time one or more fqhc services are rendered and includes a typical bundle of medicare-covered services that would be furnished per diem to a patient receiving a fqhc visit |
1,456 |
1,183 |
$41K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
303 |
294 |
$9K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
17 |
17 |
$4K |
| 99000 |
|
140 |
126 |
$710.99 |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
26 |
15 |
$554.18 |
| G8510 |
Screening for depression is documented as negative, a follow-up plan is not required |
124 |
115 |
$312.95 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
13 |
12 |
$243.91 |
| G2025 |
Payment for a telehealth distant site service furnished by a rural health clinic (rhc) or federally qualified health center (fqhc) only |
25 |
12 |
$230.15 |
| D0220 |
Intraoral - periapical first radiographic image |
24 |
24 |
$25.00 |
| 83036 |
Hemoglobin; glycosylated (A1C) |
222 |
208 |
$0.00 |
| 90686 |
|
149 |
148 |
$0.00 |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
13 |
13 |
$0.00 |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
62 |
61 |
$0.00 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
53 |
53 |
$0.00 |
| 99173 |
|
15 |
15 |
$0.00 |
| 81002 |
|
45 |
41 |
$0.00 |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
12 |
12 |
$0.00 |